🇺🇸 FDA
Pipeline program

68Ga-MGS5

FirstAHFujian-68Ga-MGS5

Phase 1 small_molecule active

Quick answer

68Ga-MGS5 for Medullary Thyroid Carcinoma is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Medullary Thyroid Carcinoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials